根據最新的財務報表(Form-10K),Revenio Group Oyj 的總資產為 $0,淨利潤為 $17
REVXF 的關鍵財務比率是什麼?
Revenio Group Oyj 的流動比率為 0,淨利潤率為 15.59,每股銷售為 $4.1。
Revenio Group Oyj 的收入按細分市場或地理位置如何劃分?
目前 Revenio Group Oyj 資料無法取得。
Revenio Group Oyj 是否盈利?
是的,根據最新的財務報表,Revenio Group Oyj 的淨利潤為 $17
Revenio Group Oyj 有負債嗎?
無,Revenio Group Oyj 的負債為 0
Revenio Group Oyj 的流通股有多少?
Revenio Group Oyj 的總流通股為 0
關鍵數據
前收市價
$25
開盤價
$25
當日範圍
$25 - $25
52週區間
$25 - $31.47
交易量
100
平均成交量
0
股息收益率
--
每股盈餘 (TTM)
0.82
市值
$667.0M
什麼是 REVENIO GROUP OYJ?
Revenio Group Oyj engages in ophthalmic diagnostics and the manufacture and sale of ophthalmic devices. The company is headquartered in Vantaa, Etela-Suomen and currently employs 247 full-time employees. The company went IPO on 2003-01-01. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. The company distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.